Key result
ABCA1 rs2230806 polymorphism linked to CVA risk in cardiovascular patients.
Why the study?
Understanding genetic predictors like the ABCA1 rs2230806 polymorphism is necessary to determine treatment tactics and predict the course of cerebrovascular accidents in patients with cardiovascular diseases.
Does the ABCA1 rs2230806 polymorphism predict the risk of cerebrovascular accident in patients with cardiovascular diseases?
Does the ABCA1 rs2230806 polymorphism predict the risk of cerebrovascular accident in patients with cardiovascular diseases?
This review highlights the potential role of the ABCA1 rs2230806 polymorphism as a genetic predictor for cerebrovascular accidents in cardiovascular patients, emphasizing the need for further targeted research.
Cerebrovascular accident (CVA) in patients with various cardiovascular diseases is a life-threatening complication, the development of which can be contributed by both environmental and genetic factors, the understanding of which is necessary to determine the tactics of treatment and predict the disease course. The article presents a brief review of studies on genetic predictors of CVA, in particular the association of the ABCA1 rs2230806 polymorphism and the risk of CVA in cardiovascular patients. Targeted studies of associations of the ABCA1 rs2230806 polymorphism with cerebrovascular diseases in the Russian Federation, except for studies at our university, could not be found.
No takes yet. Share an insight, caveat, or question.
Чернова et al. (2022) conducted a review in Cardiovascular diseases and cerebrovascular accident. ABCA1 rs2230806 polymorphism was evaluated on Cerebrovascular accident (CVA). A literature review highlights the association of the ABCA1 rs2230806 polymorphism with the risk of cerebrovascular accidents in cardiovascular patients, noting a lack of studies in Russia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: